Contact Us
Pay Invoice
Follow Us!
Latest Blogs
- Latest CDC Findings: A Wake‑Up Call for the $1.3 Billion Global Sepsis Diagnostics Market April 6, 2026
- NAMs, NIH Policy, and What it Means for Diagnostics March 20, 2026
- As Flu Outpaces COVID This Winter, Rapid Molecular Testing Takes on New Importance March 17, 2026
- March Is Colorectal Cancer Awareness Month: How Liquid Biopsy Is Shaping the Future of CRC Detection and Care February 20, 2026
- Global IVD Growth: Stability, Shifting Markets, and the Road to 2030 February 11, 2026
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Quidel-Ortho: A Merger of Contrasts
In 2021’s most notable IVD merger and acquisition, San-Diego, CA-based Quidel announced an acquisition of Raritan, N.J.-based Ortho Clinical Diagnostics. Both companies are in Kalorama’s IVD Market “Top Tier” And they couldn’t be more different. Quidel tends to sell to the clinic, Ortho Clinical to the hospital. Quidel sells flu and respiratory infectious disease tests, […]
19 Need-To-Know Developments in Cell and Gene Therapy
The following are recent developments in Cell and Gene Therapy, from Volume 1, Issue 13 of Cell and Gene Therapy Business Outlook, published December 22, 2021 Arrowhead Pharmaceuticals, based in Pasadena, CA, has completed a purchase of 13 acres in the Verona Technology Park in Verona, WI, where it plans to invest between $200 million […]
Long History of Disease Threats Boosts Blood Screening Market
From In Vitro Diagnostics Business Outlook Newsletter – Subscribe Today. Zika isn’t something covered in the news much anymore but in the blood screening IVD market, it still matters. So do all the other past disease threats to a pure blood supply, and the possible future threats. New disease threats reaching the level of concern […]
13 Need-to-Know Developments in Cell and Gene Therapy
The following are recent developments in Cell and Gene Therapy, from the latest issue of Cell and Gene Therapy Business Outlook Adicet Bio, based in Boston, MA, reported positive interim data from its Phase I dose escalation study of ADI-001, a gamma delta CAR T-cell therapy targeting CD20 for the treatment of B-cell non-Hodgkin’s lymphoma. […]
Cancer IVD: 4 Trends to Watch in $5.5 Billion Market
Whether affecting the lungs, colorectal system, stomach, liver, breasts, or other parts of the body, few medical maladies carry the inherent gravitas of cancer. Annually, millions of new cancer cases are diagnosed and millions of cancer linked deaths occur worldwide. Undoubtedly, cancer poses one of the greatest threats to human health globally. This proliferating […]
We Keep Saying The Chinese IVD Market is Growing. That’s Because it Is.
We keep saying it, but that is only because it remains true: China continues to be an untapped market for IVD manufacturers. It’s certainly not out of a desire to follow the crowd. As China’s rate of growth has slowed, we’ve noted that. Yet based on our global market analysis, the IVD market there remains […]
4 Trends to Watch in Autoimmune Immunoassay Market
The market for autoimmune immunoassays will total an estimated $971.7 million in 2021 and is forecast to exceed $1 billion by 2026, according to Autoimmune Immunoassay Brief, a recent report by leading medical market researcher Kalorama Information. The autoimmune immunoassays market—including lab-based autoimmune immunoassays and POC-based autoimmune immunoassays—is only a small part of the […]
#Meeting on the Mesa / Cell and Gene Therapy Show Cast
Cell and Gene Therapy Business Outlook Editor Blake Middleton on Significant CGT Developments at Meeting on the Mesa The Meeting on the Mesa is going on. ( https://meetingonthemesa.com/agenda/) More than 1700 attendees are at the cell and gene therapy-focused meeting, along with Science Advisory Board, LabPulse and other members of the Science and Medicine group family. […]
$54.4 Billion in Deals and Counting: Analyzing Three Quarters of Cell and Gene Therapy Funding
Over 54 BN across funding mechanisms. Private, VC, SPAC and and IPO Over 20Billion The enormous amount of funding presages confidence in discoveries of future marketable products as well as platforms in cell and gene therapy. With an aggressive third quarter 2021 for funding, it is worthwhile to total and assess where we are. In […]
Allergy Immunoassay Market at $612.5 Million with 30%-40% of World Population Affected
Allergy statistics show that allergy conditions, triggered by anything from foods to venoms to vaccines and more, are constantly present in our lives and are not going away. In fact, the rising prevalence of allergies has created a market for allergy immunoassays—including lab-based allergy immunoassays and POC-based allergy immunoassays—that will reach an estimated $612.5 […]